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Abstract
Background
Although tuberculosis (TB) is usually curable with antibiotics, poor adherence to medication
can lead to increased transmission, drug resistance, and death. Prior research has shown
several factors to be associated with poor adherence, but this problem remains a substan-
tial barrier to global TB control. We studied patients in a high-incidence district of Lima, Peru
to identify factors associated with premature termination of treatment (treatment default).
Methods
We conducted a prospective cohort study of adult smear-positive TB patients enrolled be-
tween January 2010 and December 2011 with no history of TB disease. Descriptive statis-
tics and multivariable logistic regression analyses were performed to determine risk factors
associated with treatment default.
Results
Of the 1233 patients studied, 127 (10%) defaulted from treatment. Patients who defaulted
were more likely to have used illegal drugs (OR = 4.78, 95% CI: 3.05-7.49), have multidrug-
resistant TB (OR = 3.04, 95% CI: 1.58-5.85), not have been tested for HIV (OR = 2.30, 95%
CI: 1.50-3.54), drink alcohol at least weekly (OR = 2.22, 95% CI: 1.40-3.52), be underweight
(OR = 2.08, 95% CI: 1.21-3.56), or not have completed secondary education (OR = 1.55,
95% CI: 1.03-2.33).
Conclusions
Our study identified several factors associated with defaulting from treatment, suggesting a
complex set of causes that might lead to default. Addressing these factors individually
would be difficult, but they might help to identify certain high-risk patients for supplemental
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intervention prior to treatment interruption. Treatment adherence remains a barrier to suc-
cessful TB care and reducing the frequency of default is important for both the patients’
health and the health of the community.
Introduction
In a review of medical treatment interventions, Haynes et al. posited that improving treatment
adherence “may have a far greater impact on the health of the population than any improve-
ment in specific medical treatments” [1]. Most research on medication adherence pertains to
chronic diseases, since medication is taken for an extended period of time. However, some in-
fectious diseases such as tuberculosis (TB) also require long medication regimens [2]. Treat-
ment for drug-susceptible TB consists of a two-month intensive phase of daily medication
followed by a four-month continuation phase of varying frequency, while treatment for multi-
drug-resistant TB (MDR-TB) can take substantially longer [3]. Low adherence to anti-TB med-
ication is common and can lead to death, drug resistance, continued transmission in the
community, and increased health system costs [4–6].
To ensure long-term treatment adherence, patients historically were isolated in TB sanatoria
where they were provided treatment and kept separate from non-diseased individuals. Howev-
er, studies performed in Madras, India in the late 1950s showed that this held no advantage
over treatment at home for either the patient or family and sanatoria were largely eliminated as
a TB control strategy [7–10]. Unfortunately, researchers began to find that patients did not al-
ways take medication as prescribed and direct observation of treatment began to be considered
as a strategy for enforcing medication adherence for the duration of a treatment regimen [11–
13]. Direct observation of each dose of medication has been the international standard since
the World Health Organization (WHO) adopted it as part of the Directly Observed Therapy
Short-course (DOTS) strategy in the early 1990s [14]. However, a systematic review recently
found no empirical evidence of improvement over self administration of therapy [15]. Regard-
less, TB treatment adherence remains an issue even under directly observed therapy, with cure
rates falling well below the global target of 90% [16].
Numerous papers have explored potential causes of TB treatment default (premature termi-
nation of treatment) in settings with directly observed therapy. Previous quantitative studies in
other high incidence urban settings have found alcohol abuse, recreational drug use, male gen-
der, previous treatment default, and unemployment to be associated with default from treat-
ment [17,18]. A systematic review of qualitative research found that reasons for default
generally fit into 8 specific categories: “organisation of treatment and care; interpretations of
illness and wellness; the financial burden of treatment; knowledge, attitudes, and beliefs about
treatment; law and immigration; personal characteristics and adherence behaviour; side effects;
and family, community, and household support” [19].
Although it was an early adopter of DOTS as a TB control strategy, Peru continues to face a
high burden of TB, with an incidence of 101 cases per 100,000 people as of 2011 [20]. While
5.3% of new TB cases are MDR, fully 24% of re-treated cases are classified as such [20], demon-
strating the importance of successful treatment completion. Our primary objectives were to de-
scribe the frequency of treatment default in a high-incidence district of Northeast Lima and to
identify factors associated with default in order to provide insight for policy makers and clini-
cians in improving care. We conducted a cohort study of new adult smear-positive cases of pul-
monary TB in the district, looking for factors associated with treatment default.
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Methods
Setting
The study was carried out in a semi-urban district of Northeastern Lima, Peru with a popula-
tion of approximately one million people. The district had an annual TB incidence of 213 per
100,000 residents, with seven percent of new cases classified as MDR-TB [21]. The majority of
TB cases in the district are managed at the 34 public health facilities, composed of 33 commu-
nity health clinics and one hospital. The National Tuberculosis Program has a designated office
in each of these facilities, where a nurse, a nurse aid, and supervising physician are responsible
for the detection, diagnosis, and follow up of TB suspects. Cases of TB are treated through
health center-based DOTS, with treatment provided free of cost to the patient.
Study Design
We performed a prospective cohort study among adults with a first episode of smear-positive,
pulmonary TB. Patients were enrolled between January 2010 and December 2011 and followed
up until treatment completion, death, or transfer to another jurisdiction. Trained field workers
visited the health centers daily and invited patients to participate in the study upon diagnosis
of smear-positive, pulmonary TB. Upon enrollment, field workers interviewed each patient to
collect demographic, social, and medical information with a structured questionnaire. They
did not interfere with routine patient management and treatment was carried out according to
standard Ministry of Health protocols. We used a locally developed and validated scale to de-
termine socioeconomic status [22]. HIV screening is an opt-out component of the national TB
program and results were abstracted from patients’ files if available. Treatment outcome was
obtained from patients’ charts.
Data Management and Analysis
Data were entered by single entry into a Microsoft Access database (Microsoft Corporation,
Redmond, WA, US). We checked the accuracy of variables for 10% of study subjects, reviewing
100% for a variable if mistakes were found in more than 10% of reviewed files. Where categori-
zation was not implicit, potential predictor variables were classified as follows. Alcohol use was
collected in 7 categories of increasing frequency, but dichotomized for analysis as at least week-
ly or not, based on a strong natural break in patient data. HIV status was classified as positive,
negative, or “test was not done.” Treatment outcomes were defined according to standard
WHO definitions, with treatment default defined as two months or more of continuously
missed doses [3]. We compared patients who defaulted from treatment with those of all other
outcomes. However, if any variables were associated with both treatment default and death or
another negative outcome, this dichotomization could bias resulting odds ratios (OR) toward
the null. Therefore additional analyses were conducted comparing those defaulting from treat-
ment with only those who completed treatment, as done by Franke et al. in a similar situation
previously [4]. Statistical analysis was performed using Stata 12.1 for Mac (Stata Corp., College
Station, TX, USA). Potential predictor variables were analyzed in bivariate with Chi-square
tests and OR with 95% confidence intervals (CI). The independent effect of each potential pre-
dictor variable was determined using a multivariable logistic regression model with a backward
fitting variable selection algorithm. All predictor variables associated with the outcome at a p
value of<0.2 were included in the original model.
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Ethical Considerations
The study protocol was approved by the Institutional Review Board of Universidad Peruana
Cayetano Heredia and the East Lima DISA (regional health authority). All patients provided
written informed consent and received a copy of the form. Data were managed securely and
anonymously. Patients were treated at facilities of the Ministry of Health, which covered the
cost of TB diagnosis and treatment.
Results
Subject Inclusion
Fig 1 shows the flow of participants in the study. During 2010 and 2011, a total of 1294 patients
were enrolled. One patient’s treatment was stopped by direction of medical staff, while 15 (1%)
had no record of outcome and were excluded from the analysis. An additional 45 (3%) were
missing values for independent variables and were excluded, leaving 1233 subjects in the
final analyses.
Missing data
Data were missing most frequently for socioeconomic status (2%, n = 23), with less than 2%
missing data for all other independent variables. Of the 1278 subjects with a treatment outcome
on record, 1233 (96%) had full data for the variables included in the original multivariable
model. As such, missing data were dealt with in analyses by complete case analysis.
Characteristics of the study population
Baseline socio-demographic and medical characteristics of the 1233 remaining study subjects
can be found in Table 1.
Treatment outcome
At time of analysis, 20 of the 1233 people (2%) were still on treatment, 1016 (82%) patients had
completed treatment, and 40 (3%) had transferred out of the district. Thirty patients (2%) died
during treatment. A total of 127 (10%) patients defaulted from treatment during the study peri-
od. Of these, 119 had a record of date of default, as noted by the Ministry of Health clinic.
Among these, 19 (16%) defaulted during the first 60 days after treatment initiation, whereas
100 (84%) defaulted after this first stage of treatment.
Risk factors for treatment default
Baseline alcohol use of at least once per week, low BMI at enrollment, lifetime history of illicit
drug use, less than complete secondary education, treatment for MDR-TB, history of incarcera-
tion, history of residence in a rehabilitation center, poverty or extreme poverty, male sex, cur-
rent or past smoking, and not having an HIV screening test done were all associated with
defaulting from treatment in bivariate analysis. Furthermore, being in the oldest age quartile
and having diabetes were both associated with a decreased risk of default in bivariate (see
Table 2). After multivariable logistic regression analysis, only drug use, a BMI of less than 18.5,
MDR treatment, alcohol use of at least once per week, not having been tested for HIV, and not
completing secondary education could predict a higher rate of default (see Table 2). Since none
of the diabetics defaulted from treatment, diabetes as a predictor variable was excluded from
the regression analyses. When we excluded patients who had died, had transferred out, or who
were still on treatment, and compared those who defaulted only to those who completed
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treatment, the multivariable output consisted of the same predictor variables. Only two signifi-
cant variables had odds ratios that differed by more than 10%. The OR for low BMI
(OR = 2.35, 95% CI: 1.35–4.07) increased by 13% and the odds ratio for MDR (OR = 4.49, 95%
CI: 2.22–9.09) increased by 48%.
Fig 1. Flow of cohort study participants.We initially enrolled 1294 pulmonary, smear-positive tuberculosis patients into the study. One patient was
excluded since the doctor stopped treatment early. Fifteen patients were excluded since there was no record of their treatment outcome on file. We excluded
45 patients from the analysis who were missing at least one predictor variable. Of the initial 1294 patients enrolled, 1233 remained for analysis.
doi:10.1371/journal.pone.0128541.g001
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Table 1. Characteristics of 1,233 smear-positive pulmonary tuberculosis patients.
Variables Patients (%)
Age
Median years, IQR[Interquartile range] 26, IQR[21–37]
Sex
Male 743 (60.3%)
Female 490 (39.7%)
Marital Status
Married/cohabitating 469 (38.0%)
Divorced/separated 91 (7.4%)
Single 637 (51.7%)
Widowed 36 (2.9%)
Socioeconomic Status
Not in poverty 1024 (83.0%)
Poverty or extreme poverty 209 (17.0%)
Prison History
No 1178 (95.5%)
Yes 55 (4.5%)
Completed Secondary School
No 514 (41.7%)
Yes 719 (58.3%)
Smoking
Never smoked 742 (60.2%)
Currently smokes 51 (4.1%)
Used to smoke 440 (35.7%)
Alcohol Use at Least Once Per Week
No 1000 (81.1%)
Yes 233 (18.9%)
Drug Use
No 1043 (84.6%)
Yes 190 (15.4%)
Rehab History
No 1156 (93.8%)
Yes 77 (6.2%)
MDR Treatment Status
Standard Treatment 1152 (93.4%)
MDR Treatment 81 (6.6%)
Body Mass Index (BMI)
Normal (18.5 to 24.9) 916 (74.3%)
Underweight (<18.5) 151 (12.2%)
Overweight/Obese (25 or greater) 166 (13.5%)
Chronic Disease
No 1198 (97.2%)
Yes 35 (2.8%)
HIV Status
Negative 916 (74.3%)
Positive 22 (1.8%)
Test not done 295 (23.9%)
Diabetes
No 1179 (95.6%)
Yes 54 (4.4%)
doi:10.1371/journal.pone.0128541.t001
Tuberculosis Treatment Default in Lima
PLOSONE | DOI:10.1371/journal.pone.0128541 June 5, 2015 6 / 11
Table 2. Risk factors for default from anti-tuberculosis (TB) treatment regimens compared to all other outcomes, n = 1,233.
Variable Patients N Default (%) Bivariate Analysis Multivariable Analysis
Odds Ratio (95% CI) P Odds Ratio (95% CI) P
Age .006
21 and younger 321 37 (11.5%) 1.00
22 to 26 326 36 (11.0%) 0.95 (0.59–1.55)
27 to 37 291 39 (13.4%) 1.19 (0.73–1.92)
38 and older 295 15 (5.1%) 0.41 (0.22–0.77)
Sex < .001
Female 490 29 (5.9%) 1.00
Male 743 98 (13.2%) 2.42 (1.57–3.72)
Marital Status .681
Married/cohabitating 469 45 (9.6%) 1.00
Divorced/separated 91 10 (11.0%) 1.16 (0.56–2.40)
Single 637 70 (11.0%) 1.16 (0.78–1.73)
Widowed 36 2 (5.6%) 0.55 (0.13–2.38)
Socioeconomic Status .034
Not in poverty 1024 97 (9.5%) 1.00
Poverty/extreme poverty 209 30 (14.4%) 1.60 (1.03–2.49)
Prison History <. 001
No 1178 109 (9.3%) 1.00
Yes 55 18 (32.7%) 4.77 (2.63–8.67)
Completed secondary education <. 001 .035
Yes 719 52 (7.2%) 1.00 1.00
No 514 75 (14.6%) 2.19 (1.51–3.18) 1.55 (1.03–2.33)
Smoking <. 001
Never smoked 742 50 (6.7%) 1.00
Currently smokes 51 8 (15.7%) 2.57 (1.15–5.77)
Used to smoke 440 69 (15.7%) 2.57 (1.75–3.78)
At Least Weekly Alcohol Use <. 001 <. 001
No 1000 72 (7.2%) 1.00 1.00
Yes 233 55 (23.6%) 3.98 (2.71–5.86) 2.22 (1.40–3.52)
Drug Use <. 001 <. 001
No 1043 64 (6.1%) 1.00 1.00
Yes 190 63 (33.2%) 7.59 (5.12–11.25) 4.78 (3.05–7.49)
Rehab History <. 001
No 1156 102 (8.8%) 1.00
Yes 77 25 (32.5%) 4.97 (2.96–8.34)
MDR Treatment .004 <. 001
Standard Treatment 1152 111 (9.6%) 1.00 1.00
MDR Treatment 81 16 (19.8%) 2.31 (1.29–4.13) 3.04 (1.58–5.85)
Body Mass Index (BMI) .011 .020
Normal (18.5 to 24.9) 916 91 (9.9%) 1.00 1.00
Underweight (<18.5) 151 25 (16.6%) 1.80 (1.11–2.91) 2.08 (1.21–3.56)
Overweight/Obese (> = 25) 166 11 (6.6%) 0.64 (0.34–1.23) 0.88 (0.44–1.73)
Other Chronic Disease .365
No 1198 125 (10.4%) 1.00
Yes 35 2 (5.7%) 0.52 (0.12–2.19)
HIV Status <. 001 <. 001
(Continued)
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Discussion
This study was carried out to quantify and explain the levels of treatment default in a high-inci-
dence neighborhood of Lima, Peru. We found that about ten percent of patients prematurely
defaulted from treatment, a figure lower than in some low-income settings, but still higher
than ideal [6]. The large majority of these patients defaulted after completing the intensive
phase of treatment, a pattern found in other studies as well [23]. We found that several factors
were independently associated with default among patients, including substance use and treat-
ment for MDR-TB. However, the number of significant factors identified is indicative of a
complex combination of independent causes that might affect treatment adherence.
In our study, the strongest determinant of treatment default was illicit drug use. Similarly,
frequent alcohol use was found to be a strong risk factor. These associations have been found
in many other studies of TB treatment default [4,18,24,25]. While male sex and prison or rehab
history were found to be associated with default in bivariate analysis, they are accounted for by
drug and alcohol use and other variables in the multivariable model. It is possible that sub-
stance abuse could directly cause a patient to default from treatment, but we believe it is more
likely that underlying behavioral differences or health system barriers unique to this popula-
tion—and probably a combination of both—led to this high frequency of poor treatment ad-
herence. Eliminating, or even reducing, rates of substance abuse in a population in this case
might not lead to any change in default rates, even if such a task were feasible, but future re-
search should look into the specific barriers to treatment success that this population faces so
that interventions could be designed to address these concerns.
Whereas drug and alcohol use are frequently found in the literature to be associated with a
higher risk of default, we did not find any other studies that linked a low BMI with a higher
risk for treatment default. A review of treatment outcomes for MDR-TB patients in several
countries showed a BMI under 18.5 to be associated with poor treatment outcomes including
death, but was not significantly associated with defaulting from treatment [26]. Perhaps a pa-
tient with a low BMI would be more likely to have a severe comorbidity or be malnourished.
Our study attempts to control for the major chronic comorbidities, though BMI could account
for residual effects not found in the self-reported responses.
The fact that having no HIV test done was associated with defaulting from treatment is
probably not generalizable beyond Lima. If not having been tested was randomly distributed
across patients, then this group should be no more likely to default. This finding is indicative
that tests are not being done for a systematic reason. We suggest that the local health
Table 2. (Continued)
Variable Patients N Default (%) Bivariate Analysis Multivariable Analysis
Odds Ratio (95% CI) P Odds Ratio (95% CI) P
Negative 916 72 (7.9%) 1.00 1.00
Positive 22 4 (18.2%) 2.60 (0.86–7.90) 1.39 (0.42–4.65)
Test not done 295 51 (17.3%) 2.45 (1.67–3.60) 2.30 (1.50–3.54)
Diabetes .011
No 1179 127 (10.8%) 1.00
Yes 54 0 (0.0%) .10 (0.00–0.56)a
a Odds ratio for diabetes variable was estimated using an exact logistic regression. Due to the perfect prediction for default, it was left out of the
multivariable model variable selection process.
doi:10.1371/journal.pone.0128541.t002
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authorities look into this discrepancy and work to test a higher proportion of TB patients for
HIV co-infection.
Additionally, we found that patients who underwent treatment for MDR-TB were about
three times more likely to default from treatment than those on the standard treatment regi-
men. Second-line medications are considerably more toxic than the standard medications, so it
is possible that more severe adverse effects lead to this higher rate of default [27]. However,
those on treatment for MDR-TB are also treated for a longer duration and are therefore given a
longer timeframe in which to default. Either of these explanations, but likely a combination of
the two, could explain the increased risk of default among patients being treated for MDR-TB.
Previous studies have shown mixed results regarding education and TB treatment adher-
ence [18,28,29]. We found that failing to complete secondary education was associated with de-
faulting from the treatment regimen, though only moderately. This could indicate that our
study had more power to detect a true association or that the relationship is modified by certain
systemic or population characteristics.
Although diabetes was not able to be included in the multivariable model, those with diabe-
tes appear to be less likely to default. It is possible that those patients on treatment for diabetes
are already in the habit of taking daily medication or simply more comfortable with the health-
care system [30–32]. To learn more about this relationship and any potential explanations, fu-
ture studies could look at preexisting medication routines and their effects on adherence to
TB treatment.
Our study was limited by the self-reporting of several variables, which could reduce its accu-
racy. However, the local TB program will rely on self-reported measures in their work, so our
results would be relevant for programmatic use. In addition, the study only included smear-
positive TB patients, so these findings might not be representative of all cases of TB in the area.
Furthermore, 15 of the patients had no record of treatment at the Ministry of Health facilities
upon follow up, though we enrolled each of them after treatment initiation at the health facility.
These missing outcomes are not likely to change the outcomes of the study, but it is neverthe-
less something to explore and prevent in the future. Moreover, we faced the issue of working
within a relatively homogeneous system of clinics and were unable to explore any potential sys-
temic factors that might predict default such as clinic-based therapy or clinic hours.
The results of this study are telling of a complex underlying set of determinants leading to
treatment default. Additionally, even though characteristics like drug use were highly associat-
ed with default, many patients with several risk factors were able to complete treatment suc-
cessfully. Future research should look into other elements that could explain these differences
among patients with similar risk factors, particularly regarding patient beliefs and health sys-
tem-related factors such as location of directly observed therapy, ease of travel to healthcare fa-
cilities, and clinic hours and wait times. Many of the factors we found will not lead directly to
simple interventions, since modifying patient characteristics like education levels and sub-
stance use is likely outside the scope of TB control programs. However, our findings have the
potential to help clinics identify patients at high risk for treatment default at time of diagnosis
and design interventions to reduce barriers to successful treatment for these
specific populations.
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